Skip to main content
. Author manuscript; available in PMC: 2020 Jul 1.
Published in final edited form as: Mol Cancer Res. 2019 Apr 23;17(7):1468–1479. doi: 10.1158/1541-7786.MCR-18-1327

Figure 4. R26PR;Mx1-cre;Cbfa2t3+/− moribund mice develop T-ALL with a similar disease phenotype compared to R26PR;Mx1-cre;Cbfa2t3+/+ moribund mice.

Figure 4.

(A) White blood cell (WBC), (B) red blood cell (RBC), (C) hemoglobin, (D) platelet, and (E) hematocrit counts in peripheral blood of control (n=4) and moribund (n=5) mice. Significance was determined using an unpaired t-test. (F) Representative images of hematoxylin and eosin-stained sections of fixed bone marrow, thymus, spleen, kidney, liver and brain tissues. All images were taken with a 40X objective. Scale bar, 100μM. ***p<0.0006; *p<0.05; ns, not significant.